21 August 2018
Visiongain’ has launched a new pharma report Needle-Free Delivery Technology Market 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology.
The growth of the needle-free delivery technology is driven by unmet needs such as the high incidence of needlestick injuries and the need for a more efficient method of delivering mass vaccinations in rural areas. The market will also be boosted by biological drugs and the rapid growth in emerging market patient populations with access to novel medical devices.
In this report, needle-free drug delivery technologies encompass two types of injector technologies — jet injector technology and the competing needle-free technologies (novel needle technology, inhaler technology and transdermal patch technology). Novel needle technologies include both pen needles and microneedles.
The lead analyst of the report commented "It is anticipated that the future will see continued growth in biologics-drug delivery partnering deals. Visiongain predicts that manufacturers will look to novel self-administration devices as a key way to compete as the biosimilar market continues to rise over the next few years. Moreover, the diabetes biologic drug market represents a major driver for the needle-free delivery technology market."
Leading companies featured in the report include 3M, Antares Pharma, Becton Dickinson, BioJect Medical Technologies, PharmaJet, Zogenix.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
04 August 2021
The growing use of this technology in many applications such as transplantation, drug delivery, 3D printed organs, and many others in the healthcare industry is one of the key drivers in the global 3D Printing in Healthcare Market.
02 August 2021
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
29 July 2021
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.